Gene Therapy Market Size, Trends, Analysis, and Outlook By Type (Gene silencing, Cell replacement, Gene augmentation, Others), By Vector, Viral vectors, Non-Viral vectors), By Therapeutic Area (Neurology, Oncology, Hepatology, Others), By Delivery method (In Vivo, Ex Vivo), By Route of Administration (Intravenous, Others), by Country, Segment, and Companies, 2024-2032
The global Gene Therapy market size is poised to register 18.5% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Gene Therapy market across By Type (Gene silencing, Cell replacement, Gene augmentation, Others), By Vector, Viral vectors, Non-Viral vectors), By Therapeutic Area (Neurology, Oncology, Hepatology, Others), By Delivery method (In Vivo, Ex Vivo), By Route of Administration (Intravenous, Others)
The gene therapy market is driven by the increasing interest in gene-based therapeutics for genetic diseases and acquired disorders, advancements in gene delivery vectors and genome editing technologies, and the growing investment in gene therapy research and development. By 2030, the market is expected to witness significant growth, fueled by innovations in viral vectors, non-viral vectors, and gene editing tools. Further, expanding applications in monogenic diseases, cancer immunotherapy, and regenerative medicine are anticipated to drive market expansion, enabling biopharmaceutical companies, academic institutions, and healthcare providers to develop and commercialize gene therapies that offer curative potential, long-term efficacy, and safety for patients with unmet medical needs and genetic disorders through gene replacement, gene editing, and gene modulation strategies for transformative healthcare solutions and disease management in clinical practice.
Gene Therapy Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Gene Therapy market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Gene Therapy survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Gene Therapy industry.
Key market trends defining the global Gene Therapy demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Gene Therapy Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Gene Therapy industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Gene Therapy companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Gene Therapy industry
Leading Gene Therapy companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Gene Therapy companies.
Gene Therapy Market Study- Strategic Analysis Review
The Gene Therapy market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Gene Therapy industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Gene Therapy Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Gene Therapy Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Gene Therapy market segments. Similarly, Strong market demand is encouraging Canadian Gene Therapy companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Gene Therapy market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Gene Therapy Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Gene Therapy industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Gene Therapy market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Gene Therapy Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Gene Therapy in Asia Pacific. In particular, China, India, and South East Asian Gene Therapy markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Gene Therapy Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Gene Therapy Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Gene Therapy market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Gene Therapy.
Gene Therapy Market Company Profiles
The global Gene Therapy market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Alnylam Pharmaceuticals Inc, Amgen Inc, Biogen Inc, BioMarin Pharmaceutical Inc, bluebird bio Inc, Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, Gilead Sciences Inc, Jazz Pharmaceuticals plc, Johnson & Johnson, Krystal Biotech Inc, Novartis AG, Orchard Therapeutics plc, Sarepta Therapeutics Inc, Shanghai Sunway Biotech Co. Ltd, Sibiono Genetech Co. Ltd, uniQure N.V.
Recent Gene Therapy Market Developments
The global Gene Therapy market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Gene Therapy Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Type
Gene silencing
Cell replacement
Gene augmentation
Others
By Vector
Viral vectors
Non-Viral vectors
By Therapeutic Area
Neurology
Oncology
Hepatology
Others
By Delivery method
In Vivo
Ex Vivo
By Route of Administration
Intravenous
Others
Geographical Segmentation:
Alnylam Pharmaceuticals Inc
Amgen Inc
Biogen Inc
BioMarin Pharmaceutical Inc
bluebird bio Inc
Bristol-Myers Squibb Company
F. Hoffmann-La Roche AG
Gilead Sciences Inc
Jazz Pharmaceuticals plc
Johnson & Johnson
Krystal Biotech Inc
Novartis AG
Orchard Therapeutics plc
Sarepta Therapeutics Inc
Shanghai Sunway Biotech Co. Ltd
Sibiono Genetech Co. Ltd
uniQure N.V.
Formats Available: Excel, PDF, and PPT
The gene therapy market is driven by the increasing interest in gene-based therapeutics for genetic diseases and acquired disorders, advancements in gene delivery vectors and genome editing technologies, and the growing investment in gene therapy research and development. By 2030, the market is expected to witness significant growth, fueled by innovations in viral vectors, non-viral vectors, and gene editing tools. Further, expanding applications in monogenic diseases, cancer immunotherapy, and regenerative medicine are anticipated to drive market expansion, enabling biopharmaceutical companies, academic institutions, and healthcare providers to develop and commercialize gene therapies that offer curative potential, long-term efficacy, and safety for patients with unmet medical needs and genetic disorders through gene replacement, gene editing, and gene modulation strategies for transformative healthcare solutions and disease management in clinical practice.
Gene Therapy Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Gene Therapy market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Gene Therapy survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Gene Therapy industry.
Key market trends defining the global Gene Therapy demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Gene Therapy Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Gene Therapy industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Gene Therapy companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Gene Therapy industry
Leading Gene Therapy companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Gene Therapy companies.
Gene Therapy Market Study- Strategic Analysis Review
The Gene Therapy market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Gene Therapy industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Gene Therapy Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Gene Therapy Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Gene Therapy market segments. Similarly, Strong market demand is encouraging Canadian Gene Therapy companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Gene Therapy market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Gene Therapy Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Gene Therapy industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Gene Therapy market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Gene Therapy Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Gene Therapy in Asia Pacific. In particular, China, India, and South East Asian Gene Therapy markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Gene Therapy Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Gene Therapy Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Gene Therapy market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Gene Therapy.
Gene Therapy Market Company Profiles
The global Gene Therapy market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Alnylam Pharmaceuticals Inc, Amgen Inc, Biogen Inc, BioMarin Pharmaceutical Inc, bluebird bio Inc, Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, Gilead Sciences Inc, Jazz Pharmaceuticals plc, Johnson & Johnson, Krystal Biotech Inc, Novartis AG, Orchard Therapeutics plc, Sarepta Therapeutics Inc, Shanghai Sunway Biotech Co. Ltd, Sibiono Genetech Co. Ltd, uniQure N.V.
Recent Gene Therapy Market Developments
The global Gene Therapy market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Gene Therapy Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Type
Gene silencing
Cell replacement
Gene augmentation
Others
By Vector
Viral vectors
Non-Viral vectors
By Therapeutic Area
Neurology
Oncology
Hepatology
Others
By Delivery method
In Vivo
Ex Vivo
By Route of Administration
Intravenous
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Alnylam Pharmaceuticals Inc
Amgen Inc
Biogen Inc
BioMarin Pharmaceutical Inc
bluebird bio Inc
Bristol-Myers Squibb Company
F. Hoffmann-La Roche AG
Gilead Sciences Inc
Jazz Pharmaceuticals plc
Johnson & Johnson
Krystal Biotech Inc
Novartis AG
Orchard Therapeutics plc
Sarepta Therapeutics Inc
Shanghai Sunway Biotech Co. Ltd
Sibiono Genetech Co. Ltd
uniQure N.V.
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Gene Therapy Market Overview and Key Findings, 2024
1.2 Gene Therapy Market Size and Growth Outlook, 2021- 2030
1.3 Gene Therapy Market Growth Opportunities to 2030
1.4 Key Gene Therapy Market Trends and Challenges
1.4.1 Gene Therapy Market Drivers and Trends
1.4.2 Gene Therapy Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Gene Therapy Companies
2. GENE THERAPY MARKET SIZE OUTLOOK TO 2030
2.1 Gene Therapy Market Size Outlook, USD Million, 2021- 2030
2.2 Gene Therapy Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. GENE THERAPY MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. GENE THERAPY MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
Gene silencing
Cell replacement
Gene augmentation
Others
By Vector
Viral vectors
Non-Viral vectors
By Therapeutic Area
Neurology
Oncology
Hepatology
Others
By Delivery method
In Vivo
Ex Vivo
By Route of Administration
Intravenous
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Gene Therapy Market, 2025
5.2 Asia Pacific Gene Therapy Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Gene Therapy Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Gene Therapy Market, 2025
5.5 Europe Gene Therapy Market Size Outlook by Type, 2021- 2030
5.6 Europe Gene Therapy Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Gene Therapy Market, 2025
5.8 North America Gene Therapy Market Size Outlook by Type, 2021- 2030
5.9 North America Gene Therapy Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Gene Therapy Market, 2025
5.11 South America Pacific Gene Therapy Market Size Outlook by Type, 2021- 2030
5.12 South America Gene Therapy Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Gene Therapy Market, 2025
5.14 Middle East Africa Gene Therapy Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Gene Therapy Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Gene Therapy Market Size Outlook and Revenue Growth Forecasts
6.2 US Gene Therapy Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Gene Therapy Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Gene Therapy Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Gene Therapy Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Gene Therapy Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Gene Therapy Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Gene Therapy Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Gene Therapy Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Gene Therapy Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Gene Therapy Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Gene Therapy Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Gene Therapy Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Gene Therapy Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Gene Therapy Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Gene Therapy Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Gene Therapy Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Gene Therapy Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Gene Therapy Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Gene Therapy Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Gene Therapy Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Gene Therapy Industry Drivers and Opportunities
7. GENE THERAPY MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. GENE THERAPY COMPANY PROFILES
8.1 Profiles of Leading Gene Therapy Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Alnylam Pharmaceuticals Inc
Amgen Inc
Biogen Inc
BioMarin Pharmaceutical Inc
bluebird bio Inc
Bristol-Myers Squibb Company
F. Hoffmann-La Roche AG
Gilead Sciences Inc
Jazz Pharmaceuticals plc
Johnson & Johnson
Krystal Biotech Inc
Novartis AG
Orchard Therapeutics plc
Sarepta Therapeutics Inc
Shanghai Sunway Biotech Co. Ltd
Sibiono Genetech Co. Ltd
uniQure N.V..
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Gene Therapy Market Overview and Key Findings, 2024
1.2 Gene Therapy Market Size and Growth Outlook, 2021- 2030
1.3 Gene Therapy Market Growth Opportunities to 2030
1.4 Key Gene Therapy Market Trends and Challenges
1.4.1 Gene Therapy Market Drivers and Trends
1.4.2 Gene Therapy Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Gene Therapy Companies
2. GENE THERAPY MARKET SIZE OUTLOOK TO 2030
2.1 Gene Therapy Market Size Outlook, USD Million, 2021- 2030
2.2 Gene Therapy Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. GENE THERAPY MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. GENE THERAPY MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
Gene silencing
Cell replacement
Gene augmentation
Others
By Vector
Viral vectors
Non-Viral vectors
By Therapeutic Area
Neurology
Oncology
Hepatology
Others
By Delivery method
In Vivo
Ex Vivo
By Route of Administration
Intravenous
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Gene Therapy Market, 2025
5.2 Asia Pacific Gene Therapy Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Gene Therapy Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Gene Therapy Market, 2025
5.5 Europe Gene Therapy Market Size Outlook by Type, 2021- 2030
5.6 Europe Gene Therapy Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Gene Therapy Market, 2025
5.8 North America Gene Therapy Market Size Outlook by Type, 2021- 2030
5.9 North America Gene Therapy Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Gene Therapy Market, 2025
5.11 South America Pacific Gene Therapy Market Size Outlook by Type, 2021- 2030
5.12 South America Gene Therapy Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Gene Therapy Market, 2025
5.14 Middle East Africa Gene Therapy Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Gene Therapy Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Gene Therapy Market Size Outlook and Revenue Growth Forecasts
6.2 US Gene Therapy Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Gene Therapy Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Gene Therapy Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Gene Therapy Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Gene Therapy Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Gene Therapy Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Gene Therapy Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Gene Therapy Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Gene Therapy Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Gene Therapy Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Gene Therapy Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Gene Therapy Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Gene Therapy Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Gene Therapy Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Gene Therapy Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Gene Therapy Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Gene Therapy Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Gene Therapy Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Gene Therapy Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Gene Therapy Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Gene Therapy Industry Drivers and Opportunities
7. GENE THERAPY MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. GENE THERAPY COMPANY PROFILES
8.1 Profiles of Leading Gene Therapy Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Alnylam Pharmaceuticals Inc
Amgen Inc
Biogen Inc
BioMarin Pharmaceutical Inc
bluebird bio Inc
Bristol-Myers Squibb Company
F. Hoffmann-La Roche AG
Gilead Sciences Inc
Jazz Pharmaceuticals plc
Johnson & Johnson
Krystal Biotech Inc
Novartis AG
Orchard Therapeutics plc
Sarepta Therapeutics Inc
Shanghai Sunway Biotech Co. Ltd
Sibiono Genetech Co. Ltd
uniQure N.V..
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
